✦ LIBER ✦

A randomized trial of IFNα/IL-2 with or without CDDP in advanced melanoma: An EORTC melanoma cooperative group trial

✍ Scribed by Keilholz, U.; Goey, S.H.; Punt, C.J.A.; Scheibenbogen, C.; Proebstle, T.; Salzmann, R.; Schadendorf, D.; Eggermont, A.M.M.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combination chemotherapy with or without

✍ Atzpodien, J; Neuber, K; Kamanabrou, D; Fluck, M; Bröcker, E B; Neumann, C; Rüng 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 92 KB

A randomized trial of IFNα and IL-2 ± ci

✍ U Keilholz; Heidelberg; A.M.M. Eggermont 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 126 KB

Prognostic factors for survival and fact

✍ U. Keilholz; P. Martus; C.J.A. Punt; W. Kruit; G. Mooser; D. Schadendorf; D. Lié 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 166 KB

1067 Analysis of the EORTC Melanoma Grou

✍ Eggermont, A.M.M.; Suciu, S.; Ruka, W.; Testori, A.; Kruit, W.; Punt, C.J.A.; De 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 150 KB

DOC-MEK: a double-blind randomized phase

✍ Gupta, A.; Love, S.; Schuh, A.; Shanyinde, M.; Larkin, J. M.; Plummer, R.; Natha 📂 Article 📅 2014 🏛 Oxford University Press 🌐 English ⚖ 202 KB

A Randomized Phase 2 Trial of Bevacizuma

✍ Kimberly A. Varker; Jennifer E. Biber; Cheryl Kefauver; Rhonda Jensen; Amy Lehma 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 259 KB